Delivery Order SPE2DB22D3016-SPE2DB25FAMD2
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$6.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,516.41 firm fixed-price delivery order is for the supply of 4,567,299,205 units of the pharmaceutical drug lisdexamfetamine 20 mg capsules. The contract has an ultimate completion date of February 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $5,909.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,939,598 units of the drug lisdexamfetamine 10 mg capsules. The contract has an ultimate completion date of January 16, 2025 and is a Firm Fixed Price Delivery Order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,288.12 firm-fixed-price delivery order is for the supply of 4,566,988,440 units of the medication Lisdexamfetamine 40 mg capsules. The award has an ultimate completion date of January 21, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,312.39 firm fixed-price delivery order is for the provision of 100-count packages of the pharmaceutical drug lisdexamfetamine 50 mg capsules. The award has an ultimate completion date of November 14, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,095.53 firm fixed-price delivery order contract is for the supply of 4,567,075,664 units of the drug Lisdexamfetamine 40 mg capsules. The contract does not have a set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,355.83 firm fixed-price delivery order is for the supply of 4,567,074,436 units of the medication lisdexamfetamine 40 mg capsule. The contract has an ultimate completion date of January 29, 2025 and was awarded on January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $2,375.59 for the supply of 100 capsules of 30 mg lisdexamfetamine. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 17, 2025, with a completion date of January 21, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,650.71 firm fixed-price delivery order is for the supply of 4,566,893,252 units of the prescription drug lisdexamfetamine 40 mg capsules. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,247.04 firm fixed-price delivery order is for the supply of 4,567,057,343 units of 20 mg Lisdexamfetamine capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of January 28, 2025 and was awarded on January 27, 2025. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,148,024 units of the pharmaceutical drug Lisdexamfetamine 30 mg capsules. The contract has a ceiling value of $1,770.04 and a period of performance through February 5, 2025. The contract is structured as a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and does not have any listed major...